Log in Start free →
Today’s CSR movers
CMS 3.9 ▲ 1.2
AEE 4.0 ▲ 1.2
SO 3.1 ▲ 0.8
WAT 4.0 ▼ 0.1
EIX 2.0 ▼ 0.2
NWS 4.3 ▼ 0.2
MTD 3.2 ▼ 0.5
FOXA 2.5 ▼ 1.2
PCG 2.7 ▼ 1.2
FOX 2.4 ▼ 1.6
—
—
Health Care · NYSE NYSE · LLY

Eli Lilly & Co

$1,160.00 +$3.25 +0.28% CLOSE 09.01.26 AFTER HOURS $1,159.00
Convergence score
4.1 / 5.0 STRONG BULLISH
+0.0 vs last report
Overall valuation
Overvalued
Aggregated across multiple horizons
Consensus target (12mo)
$1,307.42 +12.7%
Range $850.00 — $1,600.00
Sector
Health Care
NYSE · Tracked daily
Today's snapshot

Where the signals stand.

REPORT 09.01.26
UV Convergence Score
REPORT 09.01.26
4.1
/ 5.0
STRONG BULLISH
Consensus signal A
4.0
Consensus signal B
4.0
Consensus signal D
4.0
Rating trend signal
4.6
Analyst average
4.3
Multi-signal aggregate How CSR works →
Day Range
$1,156.85 – $1,188.33
52W Range
$712.05 – $1,292.65
Volume
2.4M
Avg Vol
2.9M
Mkt Cap
$1.03T
P/E
38.87
EPS (TTM)
$29.84
Div Yield
0.60%
Beta
0.51
Today's convergence

Convergence score sits at 4.1 with overall valuation reading as overvalued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation
Overvalued
CSR direction
STRONG BULLISH
Last close
$1,160.00
Sector
Health Care
Valuation
Three horizons
UPDATED 09.01.26
Short term
0–3 MO
No target Strong Buy
Medium term
3–12 MO
$1,292+11.4% Buy
Long term
12–36 MO
$412.86-64.4% Overvalued
Open valuation →
Analysts
Coverage & consensus
4 PANELS
Mean target (12mo)
$1,307.42 +12.7%
RANGE $850.00 — $1,600.00
Analyst consensus
Consensus rating Buy
Blended score 4.2 / 5
Analysts tracked 118
Open analysts →
Financials
Key metrics
LATEST
P/E
38.87
EPS (TTM)
$29.84
Mkt Cap
$1.03T
Div Yield
0.60%
Beta
0.51
52W Range
$712.05 – $1,292.65
Open financials →
Reports
Login for history

Sign in to view the historical report archive for this stock.

Log in →
Valuation breakdown

Three horizons, one consensus.

UPDATED 09.01.26
Short term
0–3 MO
Strong Buy
Consensus target
No target available

Current analyst consensus rating from Barchart.

Medium term
3–12 MO
Buy
Consensus target
$1,292 +11.4%
RANGE $850 – $1,600
$850NOW $1,160.00$1,600

12-month analyst consensus target across covering brokerages.

Long term
12–36 MO
Overvalued
Consensus target
$412.86 -64.4%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0
Top-level breakdown
Valuation: PE Ratio: 38.87PEG Ratio: -DE Ratio: -
Free Cash Flow: $11.07BPB Ratio: -PS Ratio: -Dividend: $1.73
Analyst coverage

Blended analyst consensus & targets.

4 PANELS · UPDATED 09.01.26
Analyst consensus RATING · SCORE · PANELS · ANALYSTS
Rating Blended score Panels Analysts
Buy 4.2 4 118
Price targets LOW · MEAN · MEDIAN · HIGH · UPSIDE
Coverage Low Mean Median High Upside
All panels $850.00 $1,307.42 $1,376.00 $1,600.00 +12.7%
Rating distribution STRONG BUY · BUY · HOLD · SELL · STRONG SELL
Coverage SB B H S SS
All panels 7 42 8 2 1
Rating trend CURRENT VS 1M / 2M / 3M
Period Rating Avg Analysts
Current Strong Buy 4.62 29
1 Mo Ago Strong Buy 4.62 29
2 Mo Ago Strong Buy 4.62 29
3 Mo Ago Strong Buy 4.63 30
Most recent analyst action LATEST DESK ACTION
Date
8/26/2026
Firm
Weiss Ratings
Action
Upgrade
Rating
Buy (B-) ➝ Buy (B)
Target
—
Related links
Financials

Full financial snapshot.

UPDATED 09.01.26
Quote snapshot 15 FIELDS
Prev Close
$1,156.73
Open
$1,188.00
Day Low
$1,156.85
Day High
$1,188.33
Bid
$1,159.40
Ask
$1,158.82
52W Low
$712.05
52W High
$1,292.65
50D Avg
$1,188.00
200D Avg
$1,060.62
Volume
2.4M
Avg Vol
2.9M
10D Avg Vol
2.7M
52W Change
57.34%
S&P 52W Change
19.81%
Valuation ratios 10 FIELDS
P/E (TTM)
38.87
P/E (Fwd)
24.56
PEG (Fwd)
1.48
P/S
12.98
P/B
30.52
Book Value
$38.00
EV/Revenue
13.56
EV/EBITDA
25.89
Mkt Cap
1.03T
Enterprise Val
1.08T
Profitability & returns 6 FIELDS
Profit Margin
33.53%
Gross Margin
83.40%
Operating Margin
54.22%
EBITDA Margin
52.35%
Return on Assets
20.36%
Return on Equity
102.29%
Growth 3 FIELDS
Revenue Growth (YoY)
47.70%
Earnings Growth (YoY)
26.20%
Earnings Growth (Q)
25.30%
Balance sheet & cash flow 11 FIELDS
Total Revenue
79.67B
EBITDA
41.71B
Total Cash
8.95B
Total Debt
54.91B
Cash / Share
$10.04
Revenue / Share
$89.02
Free Cash Flow
11.07B
Operating CF
28.08B
Debt / Equity
162.07
Current Ratio
1.35
Quick Ratio
0.68
Dividend 5 FIELDS
Fwd Dividend
6.92 (0.60%)
Dividend Yield
0.60%
Payout Ratio
21.69%
5Y Avg Yield
0.89%
Ex-Div Date
2026-08-14
Share statistics 7 FIELDS
Shares Out
891.36M
Float
888.95M
Shares Short
6.56M
% Short of Float
0.74%
Short Ratio
2.46
% Held Insiders
0.16%
% Held Institutions
85.43%
Calendar & events 5 FIELDS
Next Earnings
2026-10-29
Fiscal Year End
2025-12-31
Most Recent Qtr
2026-06-30
Last Split
2:1
Split Date
1997-10-16
Company 2 FIELDS
Industry
Drug Manufacturers - General
Employees
50,000